A traitor in our midst: Mesenchymal stem cells contribute to tumor progression and metastasis

Future Oncology

Volumn 4, Issue 6, 2008, Pages 745-749

  Mishra, Prasun J ^a   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AZACITIDINE; MEMBRANE PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN; CYTOKINE;

BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SUSPENSION; CELLULAR IMMUNITY; COLONY FORMATION; EDITORIAL; EPITHELIUM CELL; FIBROBLAST; HUMAN; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MESENCHYME CELL; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR CELL; TUMOR GROWTH; DISEASE COURSE; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; REVIEW;

CYTOKINES; DISEASE PROGRESSION; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 61449530646     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.6.745     Document Type: Editorial

References (35)

1. Mishra PJ, Humeniuk R, Medina DJ et al.: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331-4339 (2008).
2. Karnoub AE, Dash AB, Vo AP et al.: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
3. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferrin-β delivery into tumors. Cancer Res. 62, 3603-3608 (2002).
4. Studeny M, Marini FC, Dembinski JL et al.: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl Cancer Inst. 96, 1593-1603 (2004).
5. Hung SC, Deng WP, Yang WK et al.: Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 11, 7749-7756 (2005).
6. Goujon E: Recherches experimentales sur les proprietes physiologiques de la moelle des os. Journal de L'Anat et de La Physiol. 6, 399-412 (1869).
7. Friegnstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3, 393-403 (1970).
8. Friedenstein AJ, Chailakhyasn RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331-340 (1974).
9. Friedenstein AJ, Gorskaja JF, Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4, 267-274 (1976).
10. Gronthos S, Zannettino AC, Hay SJ et al.: Molecular and cellular chatacterisation of highly puriffied stromal stem cells derived from human bone marrow. J. Cell Sci. 116, 1827-1835 (2003).
11. Friedenstein AJ, Latzinik NV, Gorskaya YF, Luria EA, Moskvina IL: Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner. 18, 199-213 (1992).
12. Friedenstein AJ, Chailakhyan RK, Gerasimov UV: Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20, 263-272 (1987).
13. Owen M, Friedenstein AJ: Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42-60 (1988).
14. Caplan AI: Mesenchymal stem cells. J. Orthop. Res. 9, 641-650 (1991).
15. Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999).
16. Tavassoli M, Crosby WH: Transplantation of marrow to extramedullary sites, Science 161, 54-56 (1968).
17. Picinich SC, Mishra PJ, Glod J, Banerjee D: The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin. Biol. Ther. 7, 965-973 (2007).
18. Bianco P, Robey PG, Simmons PJ: Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313-319 (2008).
19. Ishii G, Sangai T, Oda T et al.: gone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys, Res. Commun. 309, 232-240 (2003).
20. Chauhan H, Abraham A, Phillips JR, Pringle JR, Walker RA, Jones JL: There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J. Clin. Pathol. 56, 271-276 (2003).
21. Hung SC, Kuo PY, Chang CF, Chen TH, Ho LL: α-smooth muscle actin expression and structure integrity in chondrogenesis of human mesenchymal stem cells. Cell Tissue Res. 324, 457-466 (2006).
22. Wang D, Park JS, Chu JS et al.: Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor β 1 stimulation. J. Biol. Chem. 279, 43725-43734 (2004).
23. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S: Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp. Cell Res. 304, 81-90 (2005).
24. Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417-1426 (1995).
25. Neuhuber B, Gallo G, Howard L, Kostura L, Mackay A, Fischer I: Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J. Neurosci. Res. 77, 192-204 (2004).
26. Friedman MS, Long MW, Hankenson KD: Osteogenic differentiation of human mesenchymal stem-cells is regulated by bone morphogenetic protein-6. J. Biochem. 98, 538-554 (2006).
27. Gregory CA, Prockop DJ, Spees JL: Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp. Cell Res. 306, 330-335 (2005).
28. Condeelis J, Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266 (2006).
29. Mani SA, Guo W, Liao MJ et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
30. Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233, 706-720 (2005).
31. Perez-Pomares JM, Munoz-Chapuli R: Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans. Anat. Rec. 268, 343-351 (2002).
32. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (2006).
33. Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev. Cell 14, 818-829 (2008).
34. Vernon AE, LaBonne C: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr. Biol. 14, R719-R721 (2004).
35. Jones BJ, McTaggart SJ: Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp. Hematol. 36, 733-741 (2008).